Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Juli 2015 08:01 ET | Quelle: Onconova Therapeutics

Onconova Appoints James J. Marino, Esq. to Board of Directors

NEWTOWN, Pa., July 8, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
01. Juli 2015 16:01 ET | Quelle: Onconova Therapeutics

Onconova Therapeutics, Inc. to Present Corporate Update at the Cantor Fitzgerald Healthcare Conference

NEWTOWN, Pa., July 1, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX) a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
23. Juni 2015 08:01 ET | Quelle: Onconova Therapeutics

Onconova to Host Myelodysplastic Syndromes (MDS) Key Opinion Leader Meeting on Tuesday, June 30 in New York City

NEWTOWN, Pa., June 23, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
15. Juni 2015 08:01 ET | Quelle: Onconova Therapeutics

Onconova Presents Patient Selection Criteria and Intermediate Clinical Endpoints for Rigosertib in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at EHA Annual Meeting

NEWTOWN, Pa., June 15, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
01. Juni 2015 08:01 ET | Quelle: Onconova Therapeutics

Onconova Presents Clinical Data on Rigosertib in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at the 2015 ASCO Annual Meeting

NEWTOWN, Pa., June 1, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
14. Mai 2015 16:01 ET | Quelle: Onconova Therapeutics

Onconova Therapeutics, Inc. Reports Recent Business Highlights and First Quarter 2015 Financial Results

NEWTOWN, Pa., May 14, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
13. Mai 2015 17:15 ET | Quelle: Onconova Therapeutics

Onconova Announces Multiple Rigosertib Clinical Data Presentations at the 2015 ASCO Annual Meeting

NEWTOWN, Pa., May 13, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
01. Mai 2015 08:01 ET | Quelle: Onconova Therapeutics

Onconova Presenting Nine Abstracts Related to Rigosertib at the 13th International Symposium on Myelodysplastic Syndromes (MDS)

NEWTOWN, Pa., May 1, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
21. April 2015 16:01 ET | Quelle: Onconova Therapeutics

Onconova Therapeutics, Inc. Highlights Rigosertib and Early-stage Programs at the 2015 American Association of Cancer Research (AACR) Annual Meeting

NEWTOWN, Pa., April 21, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
20. April 2015 08:01 ET | Quelle: Onconova Therapeutics

Onconova Therapeutics, Inc. Submits Pivotal Clinical Trial Protocol for IV Rigosertib in Higher-Risk Myelodysplastic Syndromes to FDA and EMA

NEWTOWN, Pa., April 20, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...

Nächste Seite